Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19591487rdf:typepubmed:Citationlld:pubmed
pubmed-article:19591487lifeskim:mentionsumls-concept:C0020924lld:lifeskim
pubmed-article:19591487lifeskim:mentionsumls-concept:C0054846lld:lifeskim
pubmed-article:19591487lifeskim:mentionsumls-concept:C0257535lld:lifeskim
pubmed-article:19591487lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:19591487lifeskim:mentionsumls-concept:C1554184lld:lifeskim
pubmed-article:19591487pubmed:issue23lld:pubmed
pubmed-article:19591487pubmed:dateCreated2009-12-3lld:pubmed
pubmed-article:19591487pubmed:abstractTextIn this study, we report on the discovery of isoxazole 1 as a potent dual inhibitor of p38alpha (IC(50) = 0.45 microM) and CK1delta (IC(50) = 0.23 microM). Because only a few effective small molecule inhibitors of CK1 have been described so far, we aimed to develop this structural class toward specific agents. Molecular modeling studies comparing p38alpha/CK1delta suggested an optimization strategy leading to design, synthesis, biological characterization, and SAR of highly potent compounds including 9 (IC(50) p38alpha = 0.006 microM; IC(50) CK1delta = 1.6 microM), 13 (IC(50) p38alpha = 2.52 microM; IC(50) CK1delta = 0.033 microM), 17 (IC(50) p38alpha = 0.019 microM; IC(50) CK1delta = 0.004 microM; IC(50) CK1epsilon = 0.073 microM), and 18 (CKP138) (IC(50) p38alpha = 0.041 microM; IC(50) CK1delta = 0.005 microM; IC(50) CK1epsilon = 0.447 microM) possessing differentiated specificity. Selected compounds were profiled over 76 kinases and evaluation of their cellular efficacy showed 18 (CKP138) to be a highly potent and dual-specific inhibitor of CK1delta and p38alpha.lld:pubmed
pubmed-article:19591487pubmed:languageenglld:pubmed
pubmed-article:19591487pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:citationSubsetIMlld:pubmed
pubmed-article:19591487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19591487pubmed:statusMEDLINElld:pubmed
pubmed-article:19591487pubmed:monthDeclld:pubmed
pubmed-article:19591487pubmed:issn1520-4804lld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:LauferStefanSlld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:KnippschildUw...lld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:PeiferChristi...lld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:AbadlehMohamm...lld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:HirnerHeidrun...lld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:HauserDominik...lld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:SchattelVeren...lld:pubmed
pubmed-article:19591487pubmed:authorpubmed-author:BischofJoachi...lld:pubmed
pubmed-article:19591487pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19591487pubmed:day10lld:pubmed
pubmed-article:19591487pubmed:volume52lld:pubmed
pubmed-article:19591487pubmed:ownerNLMlld:pubmed
pubmed-article:19591487pubmed:authorsCompleteYlld:pubmed
pubmed-article:19591487pubmed:pagination7618-30lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:meshHeadingpubmed-meshheading:19591487...lld:pubmed
pubmed-article:19591487pubmed:year2009lld:pubmed
pubmed-article:19591487pubmed:articleTitle3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.lld:pubmed
pubmed-article:19591487pubmed:affiliationDepartment of Pharmacy, Eberhard-Karls-University, Auf der Morgenstelle 8, D-72076 Tuebingen, Germany. Peifer@uni-tuebingen.delld:pubmed
pubmed-article:19591487pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19591487pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:19591487lld:chembl